KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 126 filers reported holding KALA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $34,000 | +9.7% | 24,325 | -5.3% | 0.00% | – |
| Q4 2021 | $31,000 | -55.1% | 25,696 | -2.9% | 0.00% | – |
| Q3 2021 | $69,000 | -52.1% | 26,464 | -2.3% | 0.00% | – |
| Q2 2021 | $144,000 | -7.1% | 27,093 | +17.4% | 0.00% | -100.0% |
| Q1 2021 | $155,000 | -0.6% | 23,069 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $156,000 | -12.4% | 23,008 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $178,000 | -29.9% | 23,667 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $254,000 | +106.5% | 24,207 | +72.4% | 0.00% | 0.0% |
| Q1 2020 | $123,000 | +141.2% | 14,042 | +0.7% | 0.00% | – |
| Q4 2019 | $51,000 | -1.9% | 13,942 | +1.1% | 0.00% | – |
| Q3 2019 | $52,000 | -41.6% | 13,789 | -0.7% | 0.00% | – |
| Q2 2019 | $89,000 | +6.0% | 13,885 | +35.9% | 0.00% | – |
| Q1 2019 | $84,000 | +64.7% | 10,214 | -1.5% | 0.00% | – |
| Q4 2018 | $51,000 | -32.9% | 10,369 | +34.3% | 0.00% | – |
| Q3 2018 | $76,000 | -26.9% | 7,723 | +1.8% | 0.00% | – |
| Q2 2018 | $104,000 | -27.8% | 7,583 | -16.8% | 0.00% | -100.0% |
| Q1 2018 | $144,000 | +60.0% | 9,119 | +86.6% | 0.00% | – |
| Q4 2017 | $90,000 | -26.2% | 4,887 | -8.1% | 0.00% | – |
| Q3 2017 | $122,000 | – | 5,320 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,142,360 | $7,745,000 | 4.83% |
| RA Capital Management | 10,874,613 | $73,730,000 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 43,431 | $294,462,000 | 0.93% |
| Parkman Healthcare Partners LLC | 272,445 | $1,847,000 | 0.47% |
| Samsara BioCapital, LLC | 601,162 | $4,076,000 | 0.41% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $693,000 | 0.40% |
| Eventide Asset Management | 3,450,000 | $23,391,000 | 0.36% |
| Orbimed Advisors | 5,465,030 | $37,053,000 | 0.32% |
| Vivo Capital, LLC | 786,883 | $5,335,000 | 0.24% |
| Knights of Columbus Asset Advisors LLC | 169,429 | $1,149,000 | 0.12% |